Roffman Miller Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Roffman Miller Associates's LLY Position: Q2 2026 in Review
Roffman Miller Associates increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $3.31M and bringing the position to 23,289 shares worth $27.9M. The position accounts for 1.46% of the portfolio, ranked #25.
Roffman Miller Associates first reported a position in LLY in Q2 2020 and has held it in 5 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Roffman Miller Associates held 23,289 shares of Eli Lilly worth $27.9M as of Q2 2026.
- Roffman Miller Associates bought 3,240 Eli Lilly shares in Q2 2026, an estimated $3.31M.
- Eli Lilly made up 1.46% of Roffman Miller Associates's portfolio in Q2 2026, its #25 holding.
- Roffman Miller Associates first reported a position in Eli Lilly in Q2 2020 and has held it in 5 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Roffman Miller Associates's 13F filing for Q2 2026, filed 13 Jul 2026.